WEISS ANDREW M
Follow13F filer, CIK 1357643, BOSTON, MA
WEISS ANDREW M filed a 13F-NT notice for the quarter ended 2026-06-30 on 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-NT 0001357643-26-000003
Changes against Q1 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Stakes and trades reported after 2026-06-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- TBPH THERAVANCE BIOPHARMA INC: 13D/A 0 shares, 0% of the class, 13D/A filed 2026-09-25, 0001193125-26-402801Timeline
Accepted , ingested
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0001357643-26-000003 | notice | 2026-08-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001357550-26-000033 | Theravance Biopharma, Inc. | 2026-09-28 | ||
| 13D/A 0001193125-26-402801 | TBPH | 2026-09-25 | ||
| 13F-NT 0001357643-26-000003 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-NT 0001357643-26-000002 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-NT 0001357643-13-000006 | Quarter ended 2013-06-30 | 2013-08-14 | acceptance time not in the bulk data set |